ARLG Grand Rounds: The Why and How of the ACORN Trial

Does the choice between cefepime and piperacillin-tazobactam affect the risks of acute kidney injury or neurological dysfunction in adults hospitalized with acute infection?

— Presented Friday, February 27, 2026 by Drs. Edward Qian and Todd W. Rice and moderated by Dr. Sarah Doernberg